Showing results (1-10 of 5,207) with videos related to
Sort By:
Pageof 521
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Chemotherapy and hormonal therapy in combinationV Hug, H Thames, J ClarkBritish Journal of Cancer|March 1, 1989
Predictors of hormone response for patients with ER-unknown breast tumoursV Hug, H Thames, S BentzenBritish Journal of Cancer|February 1, 1993
The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survivalV Hug, A Polyzos, S Tucker, et al.European Journal of Cancer & Clinical Oncology|August 1, 1986
Chemosensitivities of human clonogenic breast tumor cellsV Hug, H Thames, G Hortobagyi, et al.Investigational New Drugs|January 1, 1984
Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptiniumG E Umbach, V Hug, G Spitzer, et al.Cancer Research|March 1, 1984
Normalization of in vitro sensitivity testing of human tumor clonogenic cellsV Hug, H Thames, G R Blumenschein, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The results of modified use of chemotherapy for patients with metastatic breast cancerV Hug, J Clark, D JohnstonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1984
The true predictive value of the human tumor stem cell assay: does a workable assay select for treatment responders?V Hug, H Thames, D Johnston, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1985
Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assaysG E Umbach, V Hug, G Spitzer, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1986
Role of culture conditions and exposure duration in determining sensitivity of human bone marrow progenitor cells to methotrexateG E Umbach, G Spitzer, J A Ajani, et al.Pageof 521